New Delhi, India, home to one of the world’s largest homoeopathy ecosystems, is set to emerge as a global leader in the sector, driven by strong clinical expertise, large-scale practitioner networks, and internationally recognised quality certifications and standards.. India set to lead global homoeopathy with certified quality frameworks: Experts. For decades, the German homoeopathy brands have enjoyed a premium global reputation, often being perceived as the gold standard in quality, consistency, and research-backed manufacturing, AYUSH experts said.. However, they said that India is not only on track to match but even surpass them, driven by two powerful quality frameworks – the AYUSH Premium Mark and NABL accreditation.. According to industry reports, the country has over 2.5 lakh registered homoeopathy practitioners, nearly 300 teaching institutions, and millions of patients relying on homoeopathy as their primary or complementary system of medicine.. The global homoeopathy market is valued at over USD 8 to 10 billion, with Europe accounting for a significant share, historically dominated by Germany. Experts believe that quality-backed Indian brands are now well-positioned to challenge this dominance.. “The key differentiator lies in certified quality and scientific validation,” said Dr Pradeep Prajapati, Director of the All India Institute of Ayurveda .. He added that the AYUSH Premium Mark, launched by the Ministry of AYUSH, represents global-level compliance in manufacturing, safety, and quality management for AYUSH products.. The NABL certification ensures internationally benchmarked accuracy, reliability, and reproducibility in testing and quality control – aligned with ISO standards recognised across Europe and beyond, Dr Prajapati explained.. Rajeshwar Tiwari, a senior representative from the Ministry of AYUSH, said India has unmatched clinical data, practitioner strength, and patient diversity in homoeopathy.. “When this experiential advantage is supported by certified quality frameworks like AYUSH Premium and NABL, Indian homoeopathy gains scientific credibility that is globally comparable. This integration of research, regulation, and manufacturing excellence is essential for competing with established European brands,” Tiwari said.. A landmark example of this shift is Adven Biotech, which has become India’s first homoeopathy company to receive both the AYUSH Premium Mark and NABL certification.. Adesh Sharma, CEO of Adven Biotech, said AYUSH Premium and NABL are not just certificates; they are global passports for Indian homoeopathy.. “For years, Indian brands were clinically strong but undervalued internationally due to a lack of globally recognised quality benchmarks. These certifications change that perception completely and put Indian companies on the same platform as leading German manufacturers,” Sharma said.. He added that India stands to gain strategically. “Germany may have legacy, but India has scale, talent, raw mater